28 July 1993
NHS PRIORITIES IN RESEARCH AND DEVELOPMENT (R&D) RELATING TO CANCER
I am writing to seek your input into identifying NHS priorities for R&D in relation to cancer.
As you may know, a new R&D strategy for the NHS was launched in 1991. The Central Research and Development Committee (CRDC) for the NHS is advising on R&D priorities and has formed a number of Expert Advisory Groups to support this work. An Advisory Group on R&D priorities relating to cancer is being established under the chairmanship of Professor Peter Selby, University of Leeds.
A key operating feature of the Advisory Groups is widespread consultation with the NHS and interested outside bodies. We are seeking your opinion on what you consider are the most important problems and NHS needs in all fields of cancer which could usefully be addressed by research and development. You may also wish to identify opportunities of potential great value to the NHS in cancer.
Please note that what is sought are not definite research proposals. It would be helpful if your contribution could be as concise as possible and, preferably, limited to about three priority areas. Please state for each:
Evidence received from the NHS, professional
bodies, consumer groups, the research community and others will be used by
the Advisory Group to formulate specific questions that can be answered by
R&D. The consultation list is attached for your information; it would
be helpful to know of any further organisations you think should be
|© Crown copyright,
Department of Health. All rights reserved.
Last updated 22 November 2004
Page maintained by Helen Bailey
This page looks best when viewed with either MS Internet Explorer or Netscape Navigator.